| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.16 | 0.0005 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.093 | 0.002 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |